Integration of intratumoral and peritumoral CT radiomic features with machine learning algorithms for predicting induction therapy response in locally advanced non-small cell lung cancer
- PMID: 40082786
- PMCID: PMC11907900
- DOI: 10.1186/s12885-025-13804-x
Integration of intratumoral and peritumoral CT radiomic features with machine learning algorithms for predicting induction therapy response in locally advanced non-small cell lung cancer
Abstract
Objectives: To extract intratumoral, peritumoral, and integrated intratumoral-peritumoral CT radiomic features, develop multi-source radiomic models using various machine learning algorithms to identify the optimal model, and integrate clinical factors to establish a nomogram for predicting the therapeutic response to induction therapy(IT) in locally advanced non-small cell lung cancer.
Methods: This study included 209 patients with locally advanced non-small cell lung cancer (LA-NSCLC) who received IT as the training cohort, and an external validation cohort comprising 50 patients from another center. Radiomic features were extracted from intratumoral, peritumoral, and integrated intratumoral-peritumoral regions by manually delineating the gross tumor volume (GTV) and an additional 3 mm surrounding area. Three machine learning algorithms-Support Vector Machine (SVM), XGBoost, and Gradient Boosting-were employed to construct radiomic models for each region. Model performance was evaluated in the external validation cohort using metrics such as Area Under the Curve (AUC), confusion matrix, accuracy, precision, recall, and F1 score. Finally, a comprehensive nomogram integrating the optimal radiomic model with independent clinical predictors was developed.
Results: Through a comparison of optimal machine learning algorithms, INTRAPERI, INTRA, and PERI achieved the best performance with Gradient Boosting, SVM, and XGBoost, respectively. Compared to the INTRA_SVM and PERI_XGBoost INTRA models, the fusion model that integrates INTRA and peritumoral regions within a 3 mm margin around the tumor (INTRAPERI_GradientBoosting) showed better predictive performance in the training set, with AUCs of 93.7%, 82.5%, and 89.4%, respectively. In the clinical model, the PS score was identified as an independent predictive factor. The nomogram combining clinical factors with the INTRAPERI_GradientBoosting score demonstrated clinical predictive value.
Conclusion: The INTRAPERI_GradientBoosting model, which integrates intra-tumoral and peritumoral features, performs better than the INTRA intra-tumoral and PERI peritumoral radiomics models in predicting the efficacy of IT therapy in LA-NSCLC. Additionally, the nomogram based on INTRAPERI intra-tumoral and peritumoral features combined with independent clinical predictors has clinical predictive value.
Keywords: CT imaging; Induction therapy; Intra-tumoral features; Locally advanced; Machine learning; Nomogram; Non-small cell lung cancer (NSCLC); Peritumoral features; Predictive model; Radiomics.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study was approved by the Ethics Committee of Sichuan University West China Longquan Hospital (Approval No. IRB-C-F10/AF-KY-2024028) and conducted in accordance with the Declaration of Helsinki. Given that this is a retrospective analysis and all patient data were anonymized, the Ethics Committee waived the requirement for individual informed consent. Similarly, approval for the external validation cohort was obtained from the Ethics Committee of the Cancer Center of the Second Affiliated Hospital of Chongqing Medical University (Approval No. KY2024394). All data processing procedures adhered to relevant ethical standards and privacy protection regulations. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures






Similar articles
-
18F-FDG PET/CT-based intratumoral and peritumoral radiomics combining ensemble learning for prognosis prediction in hepatocellular carcinoma: a multi-center study.BMC Cancer. 2025 Feb 19;25(1):300. doi: 10.1186/s12885-025-13649-4. BMC Cancer. 2025. PMID: 39972270 Free PMC article.
-
An integrated model combined intra- and peritumoral regions for predicting chemoradiation response of non small cell lung cancers based on radiomics and deep learning.Cancer Radiother. 2023 Dec;27(8):705-711. doi: 10.1016/j.canrad.2023.05.005. Epub 2023 Nov 4. Cancer Radiother. 2023. PMID: 37932182
-
Habitat radiomics analysis for progression free survival and immune-related adverse reaction prediction in non-small cell lung cancer treated by immunotherapy.J Transl Med. 2025 Apr 3;23(1):393. doi: 10.1186/s12967-024-06057-y. J Transl Med. 2025. PMID: 40181378 Free PMC article.
-
Systematic review and epistemic meta-analysis to advance binomial AI-radiomics integration for predicting high-grade glioma progression and enhancing patient management.Sci Rep. 2025 May 8;15(1):16113. doi: 10.1038/s41598-025-98058-0. Sci Rep. 2025. PMID: 40341184 Free PMC article.
-
The application of radiomics in laryngeal cancer.Br J Radiol. 2021 Dec;94(1128):20210499. doi: 10.1259/bjr.20210499. Epub 2021 Sep 29. Br J Radiol. 2021. PMID: 34586899 Free PMC article.
Cited by
-
Letter to the Editor of Annals of Surgical Oncology Concerning "Dissecting Tumor Size Underestimation in Pancreatic Cancer: A Comparative Analysis of Preoperative Treatments".Ann Surg Oncol. 2025 Jun 30. doi: 10.1245/s10434-025-17743-6. Online ahead of print. Ann Surg Oncol. 2025. PMID: 40587070 No abstract available.
References
-
- Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024 May-Jun;74(3):229–263. 10.3322/caac.21834. Epub 2024 Apr 4. PMID: 38572751. - PubMed
-
- Bravis V, Kaur A, Walkey HC, Godsland IF, Misra S, Bingley PJ, Williams AJK, Dunger DB, Dayan CM, Peakman M, Oliver NS, Johnston DG. ADDRESS-2 management committee, patient advocate group and investigators. Relationship between islet autoantibody status and the clinical characteristics of children and adults with incident type 1 diabetes in a UK cohort. BMJ Open. 2018;8(4):e020904. 10.1136/bmjopen-2017-020904. PMID: 29622578; PMCID: PMC5893930. - PMC - PubMed
-
- Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac LR, D’Amico TA, Dilling TJ, Dowell J, Gettinger S, Gubens MA, Hegde A, Hennon M, Lackner RP, Lanuti M, Leal TA, Lin J, Loo BW Jr, Lovly CM, Martins RG, Massarelli E, Morgensztern D, Ng T, Otterson GA, Patel SP, Riely GJ, Schild SE, Shapiro TA, Singh AP, Stevenson J, Tam A, Yanagawa J, Yang SC, Gregory KM, Hughes M. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021. J Natl Compr Canc Netw. 2021;19(3):254–266. 10.6004/jnccn.2021.0013. PMID: 33668021. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical